Form 4: Gilead Sciences Director Acquires Stock Options

Gilead Sciences Director Harish Manwani acquired restricted stock units and stock options on April 30, 2026, as detailed in a Form 4 filing.

Summary

• Harish Manwani, a Director at Gilead Sciences, Inc., acquired 1,146 restricted stock units (RSUs) and was granted a non-qualified stock option for 4,884 shares.
• The RSUs vested immediately upon grant on April 30, 2026, and represent the contingent right to receive one share of Gilead's common stock.
• The stock option also vested immediately on April 30, 2026, with an exercise price of $130.84 per share and an expiration date of April 30, 2036.
• Following these transactions, Manwani beneficially owns 15,239 shares of common stock from the RSUs and 4,884 shares from the stock option.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it reports routine equity grants to a director rather than significant financial performance or strategic shifts.

Positives

• Director Harish Manwani received immediate vesting of 1,146 restricted stock units, indicating a form of equity compensation.
• Director Harish Manwani was granted a stock option for 4,884 shares with immediate vesting, demonstrating continued incentive alignment.
• The stock option has a long expiration date of April 30, 2036, providing a substantial period for potential exercise.

Future Outlook

The filing does not contain forward-looking statements or guidance regarding future financial performance. It solely reports on equity transactions by a director.

Industry Context

StockSavvy.ai notes that this Form 4 filing for Gilead Sciences (GILD) reflects standard insider equity grant practices, where directors and officers receive stock options and restricted stock units as part of their compensation. These grants are typical within the biopharmaceutical industry to incentivize long-term performance and align management interests with shareholders.

Stakeholder Impact

• Shareholders: The issuance of stock options and RSUs to a director is a standard compensation practice that can dilute existing share ownership over time, but also aligns management incentives with long-term company performance.

Key Dates

Keywords

Gilead Sciences, GILD, Form 4, Insider Trading, Stock Options, Restricted Stock Units, Equity Compensation, Director, SEC Filing